C15:0 Supplementation for Metabolic Syndrome in Young Adults

Recruiting in Palo Alto (17 mi)

Overseen by Jeffrey Schwimmer, MD

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Jeffrey B. Schwimmer, MD

Trial Summary

What is the purpose of this trial?

This study will determine changes in plasma C15:0 levels in young adults with BMI ≥ 25 in response to 12 weeks of daily oral C15:0 supplementation.

Eligibility Criteria

Inclusion Criteria

You are between 18 and 25 years old.

You weigh more than what is considered healthy for your height.

Exclusion Criteria

You are currently taking statin medications.

Patients who are currently enrolled in a clinical trial or who received an investigational study drug within 180 days of screening

Failure to give informed consent

Participant Groups

Group I: Active Active Control 1 Intervention

200mg of pentadecanoic acid (C15:0) supplementation in capsules form

Group II: Placebo Placebo Group 1 Intervention

Matching placebo in capsules form

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

UC San Diego La Jolla, CA

Who Is Running the Clinical Trial?

Jeffrey B. Schwimmer, MD Lead Sponsor

References